These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36686714)

  • 1. Efficacy and safety of weekly versus triweekly cisplatin treatment concomitant with radiotherapy for locally advanced nasopharyngeal carcinoma: A systematic review and pooled analysis.
    Tian X; Zhu Q; Zhang Z
    Front Pharmacol; 2022; 13():999027. PubMed ID: 36686714
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis.
    Chen L; Li YC; Hu M; Zhao SJ; Yang QW
    Medicine (Baltimore); 2022 Dec; 101(52):e31842. PubMed ID: 36596073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy.
    Li X; Li L; Sun R; Gao J; Li Z; Xue Y; Zhu L; Xu T; Sun C; Xi Y; Xiong W
    Eur J Med Res; 2023 Oct; 28(1):399. PubMed ID: 37794519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma: a systematic review and pooled analysis.
    Tang J; Zou GR; Li XW; Su Z; Cao XL; Wang BC
    J Cancer; 2021; 12(20):6209-6215. PubMed ID: 34539894
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    Wang K; Dong J; He S; Wang X; Jiang C; Hu P; Guo J; Cai X; Wang X
    BMC Cancer; 2019 May; 19(1):482. PubMed ID: 31117967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evidence on effectiveness of weekly vs triweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis.
    Jacinto JK; Co J; Mejia MB; Regala EE
    Br J Radiol; 2017 Nov; 90(1079):20170442. PubMed ID: 29053029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
    Mohamed A; Twardy B; Zordok MA; Ashraf K; Alkhoder A; Schrapp K; Steuer C; Chen Z; Pakkala S; Pillai R; Trad Wadsworth J; Higgins K; Beitler JJ; Ramalingam SS; Owonikoko TK; Khuri FR; Shin DM; Behera M; Saba NF
    Head Neck; 2019 May; 41(5):1490-1498. PubMed ID: 30835900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort.
    Zhu Q; Hu H; Tang LQ; You R; Zhao JJ; Weng DS; Pan QZ; Chen CL; Zhou ZQ; Tang Y; Xia JC
    J Cancer; 2018; 9(19):3447-3455. PubMed ID: 30310501
    [No Abstract]   [Full Text] [Related]  

  • 9. Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma: An updated meta-analysis based on randomized controlled trials.
    Zhu J; Zhang Z; Bian D; Chen Q; Hu Q; Ji S; Gu K
    Medicine (Baltimore); 2020 Jan; 99(1):e18663. PubMed ID: 31895831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent weekly single cisplatin vs triweekly cisplatin alone with radiotherapy for treatment of locally advanced cervical cancer: a meta-analysis.
    Zhu J; Ji S; Hu Q; Chen Q; Liu Z; Wu J; Gu K
    Cancer Manag Res; 2018; 10():1975-1985. PubMed ID: 30034252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Chemoradiotherapy Regimens and Survival Among Patients With Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis.
    Zhang B; Li MM; Chen WH; Zhao JF; Chen WQ; Dong YH; Gong X; Chen QY; Zhang L; Mo XK; Luo XN; Tian J; Zhang SX
    JAMA Netw Open; 2019 Oct; 2(10):e1913619. PubMed ID: 31626318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a treatment in patients with locoregionally advanced nasopharyngeal carcinoma (LANC) involving carotid artery invasion.
    Liu K; Wang Y; Ma L; Yang S; Zhang X
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5791-5799. PubMed ID: 35918541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of adding induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: a meta-analysis.
    Tang M; Jia Z; Zhang J
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1545-1558. PubMed ID: 32700235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
    Chan SK; Chan SY; Tong CC; Lam KO; Kwong DL; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
    Oral Oncol; 2021 Mar; 114():105158. PubMed ID: 33508707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction Chemotherapy Improved Long Term Outcomes in Stage IV Locoregional Advanced Nasopharyngeal Carcinoma.
    Wang YW; Ho SY; Lee SW; Chen CC; Litsu S; Huang WT; Yang CC; Lin CH; Chen HY; Lin LC
    Int J Med Sci; 2020; 17(5):568-576. PubMed ID: 32210706
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Li Z; Li C; Yang D; Song J; Liu T; Zhou Z; Zhou L; Kang M
    BMC Cancer; 2022 Jun; 22(1):616. PubMed ID: 35668431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of gemcitabine and cisplatin (GP)-based induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Tang M; Jia Z; Zhang J
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1561-1572. PubMed ID: 34259896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review and Meta-Analysis of Studies Comparing Concurrent Chemoradiotherapy With Radiotherapy Alone in the Treatment of Stage II Nasopharyngeal Carcinoma.
    Xu YC; Chen KH; Liang ZG; Zhu XD
    Front Oncol; 2022; 12():843675. PubMed ID: 35903695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study.
    Lv T; Wang Y; Ou D; Liu P; Qin S; Liu L; Lou P; Wang X
    Invest New Drugs; 2019 Apr; 37(2):352-359. PubMed ID: 30617703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma.
    Chen R; Lu Y; Zhang Y; He R; Tang F; Yuan W; Li Y; Zhang X
    Medicine (Baltimore); 2021 Oct; 100(42):e27475. PubMed ID: 34678878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.